Cite
HARVARD Citation
Rubbert-Roth, A. et al. (2016). Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab. RMD open. 2 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rubbert-Roth, A. et al. (2016). Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab. RMD open. 2 (1), p. . [Online].